Porous gold nanoparticles for attenuating infectivity of influenza A virus

BACKGROUND: Influenza viruses (IVs) have become increasingly resistant to antiviral drugs that target neuraminidase and matrix protein 2 due to gene mutations that alter their drug-binding target protein regions. Consequently, almost all recent IV pandemics have exhibited resistance to commercial an...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Nanobiotechnology
Egile Nagusiak: Kim, Jinyoung, Yeom, Minjoo, Lee, Taeksu, Kim, Hyun-Ouk, Na, Woonsung, Kang, Aram, Lim, Jong-Woo, Park, Geunseon, Park, Chaewon, Song, Daesub, Haam, Seungjoo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2020
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7092597/
https://ncbi.nlm.nih.gov/pubmed/32209114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12951-020-00611-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak